Invention Grant
- Patent Title: miR-150 for the treatment of blood disorders
- Patent Title (中): miR-150用于治疗血液疾病
-
Application No.: US13652672Application Date: 2012-10-16
-
Publication No.: US08530443B2Publication Date: 2013-09-10
- Inventor: Jun Lu , Shangqin Guo , Benjamin Ebert , David Scadden , Todd Golub
- Applicant: Jun Lu , Shangqin Guo , Benjamin Ebert , David Scadden , Todd Golub
- Applicant Address: US MA Boston US MA Cambridge US MA Boston
- Assignee: The General Hospital Corporation,Massachusetts Institute of Technology,Dana-Farber Cancer Institute, Inc.
- Current Assignee: The General Hospital Corporation,Massachusetts Institute of Technology,Dana-Farber Cancer Institute, Inc.
- Current Assignee Address: US MA Boston US MA Cambridge US MA Boston
- Agency: Nixon Peabody LLP
- Agent David S. Resnick
- Main IPC: C12N15/11
- IPC: C12N15/11 ; A61K48/00 ; C07H21/02 ; C07H21/04
Abstract:
The invention provides methods of treating certain blood related disorders, in particular, thrombocytopenia and anemia comprising increasing miR-150 expression or inhibiting miR-150 in progenitor cells respectively.
Public/Granted literature
- US20130039895A1 MIR-150 FOR THE TREATMENT OF BLOOD DISORDERS Public/Granted day:2013-02-14
Information query
IPC分类:
